DK200301392A - General method for propagating and detecting pathogenic bacteria - Google Patents
General method for propagating and detecting pathogenic bacteria Download PDFInfo
- Publication number
- DK200301392A DK200301392A DK200301392A DKPA200301392A DK200301392A DK 200301392 A DK200301392 A DK 200301392A DK 200301392 A DK200301392 A DK 200301392A DK PA200301392 A DKPA200301392 A DK PA200301392A DK 200301392 A DK200301392 A DK 200301392A
- Authority
- DK
- Denmark
- Prior art keywords
- propagating
- selective
- pathogenic bacteria
- propagation
- procedure according
- Prior art date
Links
- 244000052616 bacterial pathogen Species 0.000 title description 7
- 230000001902 propagating effect Effects 0.000 title description 5
- 238000007429 general method Methods 0.000 title 1
- 238000000034 method Methods 0.000 description 27
- 230000003321 amplification Effects 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960001506 brilliant green Drugs 0.000 description 2
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 229940107698 malachite green Drugs 0.000 description 2
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- HPQYKCJIWQFJMS-UHFFFAOYSA-L tetrathionate(2-) Chemical compound [O-]S(=O)(=O)SSS([O-])(=O)=O HPQYKCJIWQFJMS-UHFFFAOYSA-L 0.000 description 2
- 241000589876 Campylobacter Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- -1 down Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000011059 hazard and critical control points analysis Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
PATENTKRAV 1. Horisontal fremgangsmåde til opformering og påvisning af patogene bakterier i en prøve herunder Salmonella, Listeria, E. coli, Campylobacter, Yersinia mfl. fra fæces, levnedsmidler, foder og øvrige produkter mennesker eller hus- og kæledyr kan indtage eller kan komme i kontakt med, hvor øvrige produkter indbefatter, men er ikke afgrænset til fjer, støv, dun, spildevand og HACCP- prøver. hvilken fremgangsmåde som minimum indbefatter: - en opformering af patogene target-bakterier i en præ-opformeringsbuffer og - en overførsel af et transfervolume (et delvolume af præ-opformeringsbufferen) til en for target-bakterieme selektiv opformeringsbuffer, hvilken selektiv opformeringsbuffer som minimum indeholder en 'agent' der ikke tåles eller tåles dårligere af 'non-target' bakterierne (følge floraen) eller andre selektive pres på 'non-target' bakterierne fx pH og osmose,PATENT REQUIREMENTS 1. Horizontal method for propagating and detecting pathogenic bacteria in a sample including Salmonella, Listeria, E. coli, Campylobacter, Yersinia, etc. from faeces, food, feed and other products humans or pets can ingest or can enter contact with where other products include but are not limited to feathers, dust, down, wastewater and HACCP samples. which method comprises at least: - a propagation of pathogenic target bacteria in a pre-propagation buffer; and - a transfer of a transfer volume (a sub-volume of the pre-propagation buffer) to a target bacterial selective propagation buffer, which at least contains a propagation buffer. 'agent' that is not tolerated or tolerated worse by the 'non-target' bacteria (following the flora) or other selective pressure on the 'non-target' bacteria such as pH and osmosis,
KENDETEGNET VED - at præ-opformeringsmedie er opvarmet til over stuetemperatur, fortrinsvis over28°C, - at transfervolumet fra præopformeringen til den selektive opformering foretages efter mindre end 14 timer og - at transfervolumet er på fortrinsvis mindst 1 ml resp. mindst 1/200 af det selektive vækstmedie. 2. Fremgangsmåde iflg. krav 1 KENDETEGNET VED at koncentrationen af vækstmediet i den modtagne selektive opformeringsbuffer har en vækstmediekoncentration, der er lig med eller væsentlig højere end anbefalet af vækstmedieproducenten eller godkendte fremgangsmåder for den patogene target-bakterie efter at transfervolumet er blevet tilført det selektive vækstmedie. 3. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at præopformeringsmediet er forvarmet til en temperatur fortrinsvis over 30DC, mere fortrinsvis over 32°C, mest fortrinsvis over 34°C. 4. Fremgangsmåde iflg. krav 1 KENDETEGNET VED at præ-opformeringsmediet er forvarmet til 37°C +/- 3°C, fortrinsvis til 37°C . 5. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at overførslen af et transfervolume fra præopformeringen til den selektive opformering fortrinsvis foretages efter mindre end 12 timer, mere fortrinsvis efter 6 +/- 4, mere fortrinsvis efter 6 +/- 2 timer, mest fortrinsvis efter 6 timer. 6. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at overførslen af et transfervolume fra præopformeringen til den selektive opformering fortrinsvis foretages efter mindre end 2 timer. 7. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at transfervolume fra præopformeringen til den selektive opformering fortrinsvis er på mindst 2 ml, fortrinsvis er på mindst 5 ml, fortrinsvis er på mindst 10 ml, fortrinsvis er på mindst 20 ml, fortrinsvis er på mindst 50 ml, resp. fortrinsvis mindst 1/100, fortrinsvis mindst 1/40, fortrinsvis mindst 1/20, fortrinsvis mindst 1/10, fortrinsvis mindst 1/4 af det selektive vækstmedie. 8. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at fremgangsmåden anvendes til afklaring af tilstedeværelsen af en enkelt patogen bakterie i et undersøgt produkt. 9. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at den patogene bakterie er salmonella. 10. Fremgangsmåde iflg. krav KENDETEGNET VED at der anvendes SELECTA BIOLINE substrat ved den selektive opformering. 11. Fremgangsmåde til opformering og påvisning af patogene bakterieri en prøve iflg. ethvert af de forgående krav KENDETEGNET VED at der anvendes en præopformeringsbuffer og mindst 2 selektive vækstmedier. 12. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at det initielle opformeringsmedie tilsættes vækstfremmere, resuscitationsfremmere eller selektive eller delvis selektive stoffer såsom selenit, tetrathionat, Novobiocin, antibiotika, Brilliantgrønt eller Malakitgrønt. 13. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at den selektive opformering forkortes til 1,2, 4, 6, 8 eller 17 timer. 14. Fremgangsmåde iflg. ethvert af de forgående krav KENDETEGNET VED at den anden buffer anvendt ved opformeringen af targetorganismer indeholder tetrathionat, Brilliantgrønt eller Malakitgrønt. 15. Fremgangsmåde til opformering og påvisning af (eventuelle) patogene bakterier i en prøve iflg. ethvert af de forgående krav KENDETEGNET VED at der ved detektionstrinet anvendes en analysemetode, der er indbefattet af, men ikke afgrænset til: affinitets bindings teknikker såsom enzyme immunoassays (ELISA) baseret på antigenantistof reaktioner, antigen-antistof reaktioner der involverer fluorescens, luminescens, evanescent waves, plasmon resonance, latex agglutination, electrokemisk immune detektion, teknikker med immunmagnetisk indfangning, teknikker med lateral flow, DNA hybridisering baseret på specifikke sekvenser af salmonella DNA molekylet, RNA-DNA, RNA-RNA, Polymerase Chain Reaction (PCR) baseret på multiplikation ved hjælp af specifikke DNA primere, ledningsevnemålemetode baseret på ændring i elektrisk modstand i særlige vækstmedier, mikroskopi, teknikker med micro arrays, CCD kamera teknik, enzym immuno teknik baseret på chromogen, fluorescens, luminescens, radioaktiv signal genererende respons, halvflydende agarer og faste agarer eller kombination med yderligere opformeringsprocedurer. 16. Fremgangsmåde til opformering og påvisning af (eventuelle) patogene bakterier i en prøve iflg. ethvert af de forgående krav KENDETEGNET VED at der ved detektionstrinet anvendes ELISA test kit fra Bioline ApS. 17. Fremgangsmåde iflg, ethvert af de forgående krav KENDETEGNET VED at overførslen af transfervolumet fra præopformeringen til den selektive opformering foretages automatisk eller semiautomatisk.FEATURED BY - that the pre-propagation medium is heated to above room temperature, preferably above 28 ° C, - that the transfer volume from the pre-amplification to the selective propagation is made after less than 14 hours, and - that the transfer volume is preferably at least 1 ml and at least 1/200 of, respectively. the selective growth medium. 2. Procedure according to Claim 1, characterized in that the concentration of the growth medium in the received selective amplification buffer has a growth media concentration equal to or substantially higher than recommended by the growth media manufacturer or approved methods for the pathogenic target bacterium after the transfer volume has been applied to the selective growth medium. 3. Procedure according to any of the preceding claims characterized by the pre-propagation medium being preheated to a temperature preferably above 30 ° C, more preferably above 32 ° C, most preferably above 34 ° C. 4. Procedure according to Claim 1, characterized in that the pre-propagation medium is preheated to 37 ° C +/- 3 ° C, preferably to 37 ° C. 5. Procedure according to any of the preceding claims characterized in that the transfer of a transfer volume from the pre-amplification to the selective amplification is preferably done after less than 12 hours, more preferably after 6 +/- 4, more preferably after 6 +/- 2 hours, most preferably after 6 hours. . 6. Procedure According to any of the foregoing claims characterized by the transfer of a transfer volume from the pre-amplification to the selective amplification preferably after less than 2 hours. 7. Procedure according to any of the preceding claims characterized in that the transfer volume from the pre-amplification to the selective amplification is preferably at least 2 ml, preferably at least 5 ml, preferably at least 10 ml, preferably at least 20 ml, preferably at least 50 ml, and preferably at least 1/100, preferably at least 1/40, preferably at least 1/20, preferably at least 1/10, preferably at least 1/4 of the selective growth medium. 8. Procedure According to any of the foregoing claims characterized by the method being used to clarify the presence of a single pathogenic bacterium in a tested product. 9. Procedure according to any of the foregoing claims characterized by the pathogenic bacterium being salmonella. 10. Procedure According to CHARACTERISTICS CHARACTERIZED BY SELECTING BIOLINE SUBSTRATE IN SELECTIVE AMPLIFICATION. 11. Method for propagating and detecting pathogenic bacteria according to a sample. any of the foregoing claims FEATURED using a pre-propagation buffer and at least 2 selective growth media. 12. Procedure According to ANY OF THE PRIOR REQUIREMENTS CHARACTERED BY the initial propagation medium being added to growth promoters, resuscitation promoters or selective or partially selective substances such as selenite, tetrathionate, novobiocin, antibiotics, brilliant green or malachite green. 13. Procedure according to any of the foregoing claims characterized by the selective amplification being shortened to 1.2, 4, 6, 8 or 17 hours. 14. Procedure According to any of the foregoing claims FEATURED that the second buffer used in the propagation of target organisms contains tetrathionate, brilliant green, or malachite green. Method of propagating and detecting (if any) pathogenic bacteria in a sample according to. ANY OF THE PRIOR REQUIREMENTS CHARACTERIZED IN THE DETECTION STEP USING AN ANALYTICAL METHOD INCLUDED BUT NOT LIMITED TO: affinity binding techniques such as enzyme immunoassays (ELISA) based on antigen antibody reactions, antigen-antibody reactions involving fluorescence, luminescence, evanescent waves, plasmon resonance, latex agglutination, electrochemical immune detection, immunomagnetic capture techniques, lateral flow techniques, DNA hybridization based on specific sequences of the salmonella DNA molecule, RNA DNA, RNA RNA, Polymerase Chain Reaction (PCR) based on multiplication using specific DNA primers, conductivity measurement method based on change in electrical resistance in particular growth media, microscopy, techniques with micro arrays, CCD camera technique, enzyme immuno-technique based on chromogen, fluorescence, luminescence, radioactive signal generating response, semi-liquid agar and solid agar or combination with outer edges tighter propagation procedures. 16. Method of propagating and detecting (any) pathogenic bacteria in a sample according to. ANY OF THE PRIOR REQUIREMENTS CHARACTERIZED BY using the ELISA test kit from Bioline ApS at the detection stage. 17. A method according to any of the preceding claims, characterized in that the transfer of the transfer volume from the pre-amplification to the selective amplification is carried out automatically or semi-automatically.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200301392A DK200301392A (en) | 2003-09-25 | 2003-09-25 | General method for propagating and detecting pathogenic bacteria |
| PCT/DK2004/000648 WO2005028668A1 (en) | 2003-09-25 | 2004-09-23 | General method for enrichment and detection of pathogen bacteria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200301392A DK200301392A (en) | 2003-09-25 | 2003-09-25 | General method for propagating and detecting pathogenic bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK200301392A true DK200301392A (en) | 2005-03-26 |
Family
ID=34354366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK200301392A DK200301392A (en) | 2003-09-25 | 2003-09-25 | General method for propagating and detecting pathogenic bacteria |
Country Status (2)
| Country | Link |
|---|---|
| DK (1) | DK200301392A (en) |
| WO (1) | WO2005028668A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102353768B (en) * | 2011-07-07 | 2013-11-27 | 清华大学深圳研究生院 | Quantum dot based immunofluorescence detection method for malachite green and special kit |
| CN104651483B (en) * | 2013-11-19 | 2017-01-18 | 北京市理化分析测试中心 | Method for detecting living bacteria body of salmonella in sample |
| WO2017040365A1 (en) * | 2015-09-03 | 2017-03-09 | 3M Innovative Properties Company | Method of enriching and detecting a target microorganism |
| CN105203766B (en) * | 2015-09-29 | 2017-01-11 | 河南省科学院生物研究所有限责任公司 | Preparation method for pathogenic yersinia enterocolitica test strips |
| CN110658338A (en) * | 2019-09-12 | 2020-01-07 | 武汉大学 | Portable mastitis pathogen MRSA detection method in lactation period |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100801A (en) * | 1989-01-26 | 1992-03-31 | Biocontrol Systems, Inc. | Device for sequential microbial enrichment in a single apparatus |
-
2003
- 2003-09-25 DK DK200301392A patent/DK200301392A/en not_active Application Discontinuation
-
2004
- 2004-09-23 WO PCT/DK2004/000648 patent/WO2005028668A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005028668A1 (en) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sohrabi et al. | State of the art: Lateral flow assays toward the point‐of‐care foodborne pathogenic bacteria detection in food samples | |
| Valderrama et al. | Commercially available rapid methods for detection of selected food-borne pathogens | |
| Deisingh et al. | Detection of infectious and toxigenic bacteria | |
| Zhao et al. | Advances in rapid detection methods for foodborne pathogens | |
| Wang et al. | Culture‐independent rapid detection methods for bacterial pathogens and toxins in food matrices | |
| Singh et al. | Evaluation of gold nanoparticle based lateral flow assays for diagnosis of enterobacteriaceae members in food and water | |
| Brandao et al. | Multiplexed detection of foodborne pathogens based on magnetic particles | |
| Dwivedi et al. | Detection of pathogens in foods: the current state-of-the-art and future directions | |
| Lin et al. | Immuno-and nucleic acid-based current technique for Salmonella detection in food | |
| Zhang | Foodborne pathogenic bacteria detection: an evaluation of current and developing methods | |
| Glynn et al. | Current and emerging molecular diagnostic technologies applicable to bacterial food safety | |
| Dao et al. | Rapid and sensitive detection of Salmonella based on microfluidic enrichment with a label-free nanobiosensing platform | |
| Zhang et al. | Sensitive and specific detection of E. coli, Listeria monocytogenes, and Salmonella enterica serovar Typhimurium in milk by microchip electrophoresis combined with multiplex PCR amplification | |
| Wu et al. | Rotary valve-assisted fluidic system coupling with CRISPR/Cas12a for fully integrated nucleic acid detection | |
| CN114487401B (en) | A dual-aptamer functional nucleic acid thermostatic microfluidic chip sensor for microbial detection | |
| Zhang et al. | Recent advances in microchip-based methods for the detection of pathogenic bacteria | |
| WO2005001475A3 (en) | Apparatus and method for detecting microscopic living organisms using bacteriophage | |
| Kumar et al. | Aptamer technology for the detection of foodborne pathogens and toxins | |
| Sun et al. | Review of recent advances in improved lateral flow immunoassay for the detection of pathogenic Escherichia coli O157: H7 in foods | |
| Feng | Emergence of rapid methods for identifying microbial pathogens in foods | |
| Safavieh et al. | Microfluidic biosensors for high throughput screening of pathogens in food | |
| Baraketi et al. | Foodborne pathogens detection: persevering worldwide challenge | |
| Cimaglia et al. | Detection of L. monocytogenes in enrichment cultures by immunoseparation and immunosensors | |
| Fronczek et al. | Detection of foodborne pathogens using biosensors | |
| DK200301392A (en) | General method for propagating and detecting pathogenic bacteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |